Cary, NC, United States of America

Paul N Mudd, Jr

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Paul N Mudd, Jr: Innovator in Pharmaceutical Treatments

Introduction

Paul N Mudd, Jr. is a notable inventor based in Cary, NC (US), recognized for his contributions to pharmaceutical innovations. He holds a total of 10 patents, focusing on treatments for various medical conditions, particularly in urology and oncology.

Latest Patents

Among his latest patents, Mudd has developed Vibegron for the treatment of overactive bladder symptoms. This method involves orally administering an amount of vibegron ranging from about 60 mg to about 90 mg per day to men suffering from benign prostatic hyperplasia. Additionally, he has worked on methods for treating prostate cancer, which include administering at least 80 mg of a specific compound once daily, as well as a regimen involving an oral load dose formulation followed by a maintenance dose.

Career Highlights

Mudd has had a significant career in the pharmaceutical industry, working with prominent companies such as Takeda Pharmaceutical Company Limited and Sumitomo Pharma Switzerland GmbH. His work has contributed to advancements in medical treatments that improve patient outcomes.

Collaborations

Throughout his career, Mudd has collaborated with various professionals, including Vijaykumar Reddy Rajasekhar and Brendan Mark Johnson. These collaborations have likely enhanced the development and implementation of his innovative treatments.

Conclusion

Paul N Mudd, Jr. stands out as a key figure in the field of pharmaceutical inventions, with a focus on improving treatments for overactive bladder symptoms and prostate cancer. His contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…